RxDoctor Payments Data

Nicole Larrison

Family · Washington, MONPI 1326338369

Payments from drug & device makers

$2,032in general payments, 2019–2025

Across 107 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$370
  • AstraZeneca$338
  • AbbVie$139
  • Amgen$124
  • Lilly USA, LLC$109
  • Otsuka America Pharmaceutical, Inc.$93
  • plus $859 from 22 others

What the payments were for

  • Food & beverage$2,032100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,032 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$32,294
Medicare patients
136
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$41,143
EliquisApixaban11$11,378
Omeprazole49$1,227
Albuterol Sulfate HfaAlbuterol Sulfate50$836
Atorvastatin Calcium104$770
Duloxetine Hcl31$736
Estradiol13$640
Levothyroxine Sodium38$525
Doxycycline Hyclate42$487
Mirtazapine12$393
Tamsulosin Hcl39$391
Warfarin Sodium13$361
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$341
Losartan Potassium47$313
Gabapentin13$307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$370$41,14339 claims
PfizerEliquis$57$11,37811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Washington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →